Logan Capital Management Inc Eli Lilly & CO Transaction History

Logan Capital Management Inc

$2.24 Billion
Q2 2024

A detailed history of Logan Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Logan Capital Management Inc holds 32,447 shares of LLY stock, worth $29.5 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

32,447

Previous 32,509 0.19%

Holding current value

$29.5 Million

Previous $25.3 Million 16.16%

% of portfolio

1.31%

Previous 1.12%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $44,941 - $56,360	-62 Reduced 0.19%	32,447 $29.4 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $53,298 - $71,305	-90 Reduced 0.28%	32,509 $25.3 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $1.41 Million - $1.67 Million	-2,691 Reduced 7.63%	32,599 $19 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $131,279 - $180,988	302 Added 0.86%	35,290 $19 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $68,043 - $90,982	194 Added 0.56%	34,988 $16.4 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $104,682 - $122,944	337 Added 0.98%	34,794 $11.9 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $1.36 Million - $1.58 Million	4,221 Added 13.96%	34,457 $12.6 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.32 Million - $1.5 Million	4,454 Added 17.28%	30,236 $9.78 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $44,970 - $55,808	200 Added 0.78%	25,782 $7.12 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $68,850 - $89,129	419 Added 1.67%	25,582 $4.78 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $15,916 - $21,060	-122 Reduced 0.48%	25,163 $4.25 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $38,061 - $45,806	-279 Reduced 1.09%	25,285 $4.15 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $241,671 - $299,120	-2,030 Reduced 7.36%	25,564 $3.55 Million
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $3,207 - $3,972	30 Added 0.11%	27,594 $3.63 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $20,814 - $24,500	-187 Reduced 0.67%	27,564 $3.58 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $16,055 - $20,066	187 Added 0.68%	27,751 $2.98 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $4,466 - $5,125	-59 Reduced 0.21%	27,564 $2.35 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $48,681 - $57,465	-656 Reduced 2.32%	27,623 $2.14 Million
Q2 2017 Aug 14, 2017	BUY	N/A	28,279	28,279 $2.33 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.

Account

Logan Capital Management Inc Eli Lilly & CO Transaction History